COVID-19 IBD Advice

First published on 04 Sep 2021

BSG Inflammatory Bowel Disease Section and Clinical Research Group Position Statement on SARS-CoV2 Vaccination

Our advice and guidance around COVID-19 is being regularly reviewed. Visit https://www.bsg.org.uk/covid-19-advice/ to see the latest published guidance. British Society of Gastroenterology Inflammatory Bowel Disease Section and IBD Clinical Research Group position statement on SARS-CoV2 Vaccination The Inflammatory Bowel Disease […]

First published on 09 Jun 2020

Adaptations to the BSG guidelines on the management of acute severe ulcerative colitis in the context of the COVID-19 pandemic: a RAND appropriateness panel

Our advice and guidance around COVID-19 is being regularly reviewed. Visit https://www.bsg.org.uk/covid-19-advice/ to see the latest published guidance. Abstract: Objective Management of acute severe ulcerative colitis (ASUC) during the novel coronavirus 2019 (COVID-19) pandemic presents significant dilemmas. We aimed to […]

First published on 24 Apr 2020

Guidance for management of inflammatory bowel disease during the COVID-19 pandemic

Our advice and guidance around COVID-19 is being regularly reviewed. Visit https://www.bsg.org.uk/covid-19-advice/ to see the latest published guidance. The COVID-19 pandemic is putting unprecedented pressures on healthcare systems globally. Early insights have been made possible by rapid sharing of data […]

First published on 30 Mar 2020

BSG expanded consensus advice for the management of IBD during the COVID-19 pandemic

Our advice and guidance around COVID-19 is being regularly reviewed. Visit https://www.bsg.org.uk/covid-19-advice/ to see the latest published guidance. Introduction Inflammatory Bowel Disease (IBD), comprising Crohn’s Disease (CD) and Ulcerative Colitis (UC), is a condition in which the gastrointestinal immune system […]